Cariprazine: Difference between revisions
| [pending revision] | [pending revision] |
Assign pharmacological categories from List_of_CNS-active_medicines |
MDElliottMD (talk | contribs) Comprehensive categorization: +Third-Generation Antipsychotics |
||
| Line 35: | Line 35: | ||
[[Category:Second-Generation Antipsychotics (SGAs / Atypicals)]] | [[Category:Second-Generation Antipsychotics (SGAs / Atypicals)]] | ||
[[Category:Neuroleptics]] | [[Category:Neuroleptics]] | ||
[[Category:Third-Generation Antipsychotics]] | |||
Revision as of 18:42, 15 May 2026
Antipsychotic, Neuroleptic
Cariprazine
Vraylar
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antipsychotic, Neuroleptic
Pharmacy
Pharmacology
Purported mechanism
D3/D2 partial agonist; 5-HT2A antagonist